BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 10727301)

  • 21. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Amo Y; Ohkawa T; Tatsuta M; Hamada Y; Fujimura T; Katsuoka K; Hashimoto T
    J Dermatol Sci; 2001 May; 26(1):14-8. PubMed ID: 11323216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.
    Fairley JA; Bream M; Fullenkamp C; Syrbu S; Chen M; Messingham KN
    J Am Acad Dermatol; 2013 Mar; 68(3):395-403. PubMed ID: 23083837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
    Zillikens D
    Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.
    Pomponi D; Di Zenzo G; Zennaro D; Calabresi V; Eming R; Zuzzi S; Bernardi ML; Scala E; Mari A
    Br J Dermatol; 2013 Jun; 168(6):1205-14. PubMed ID: 23252883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary peptides against the major epitope in the NC16A domain of BP180 show no specificity as vaccines to bullous pemphigoid.
    Nie Z; Garrod DR; Chan LS; Hashimoto T
    J Dermatol Sci; 1999 Nov; 21(3):157-64. PubMed ID: 10527376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
    Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).
    Olivry T; Borrillo AK; Xu L; Dunston SM; Slovis NM; Affolter VK; Demanuelle TC; Chan LS
    Vet Immunol Immunopathol; 2000 Jan; 73(1):45-52. PubMed ID: 10678397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid.
    Mersmann M; Dworschak J; Ebermann K; Komorowski L; Schlumberger W; Stöcker W; Zillikens D; Probst C; Schmidt E
    Arch Dermatol Res; 2016 Jan; 308(1):31-8. PubMed ID: 26498290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune response against the bullous pemphigoid 180 autoantigen.
    Liu Z; Diaz LA; Giudice GJ
    Dermatology; 1994; 189 Suppl 1():34-7. PubMed ID: 7519485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid.
    Kobayashi M; Amagai M; Kuroda-Kinoshita K; Hashimoto T; Shirakata Y; Hashimoto K; Nishikawa T
    J Dermatol Sci; 2002 Dec; 30(3):224-32. PubMed ID: 12443845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
    Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
    Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.